MedPath

The effects of sitagliptin on lipid and glucose metabolism

Phase 4
Completed
Conditions
Type 2 Diabetes
Registration Number
JPRN-jRCT1091220036
Lead Sponsor
Masumi Ai, MD, PhD Bioethics Research Center, Tokyo Medical and Dental University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria

Patients with type 2 diabetes

Exclusion Criteria

Those on insulin therapy, oral glucose-lowering medication, or lipid-lowering medication

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath